Literature DB >> 7961786

Microfibril-associated glycoprotein binds to the carboxyl-terminal domain of tropoelastin and is a substrate for transglutaminase.

P Brown-Augsburger1, T Broekelmann, L Mecham, R Mercer, M A Gibson, E G Cleary, W R Abrams, J Rosenbloom, R P Mecham.   

Abstract

Microfibril-associated glycoprotein (MAGP) is an integral component of microfibrillar structures that play a critical role in the organization of elastic fibers in the extracellular matrix. To study possible molecular interactions between MAGP and other elastic fiber components, we have generated native MAGP using a baculovirus expression system and tested its ability to associate with tropoelastin and fibrillin. MAGP produced by SF9 cells underwent processing similar to the mammalian protein, including correct cleavage of the signal peptide and sulfation of tyrosine residues. When tested in solid-phase binding assays, native MAGP specifically bound to tropoelastin but not fibrillin-1. Binding to tropoelastin was divalent cation-independent and was completely blocked by reduction and alkylation of either protein. Antibody inhibition studies indicated that the carboxyl terminus of tropoelastin mediated its interaction with MAGP. In addition to binding to elastin, MAGP was also a substrate for transglutaminase, which might explain its propensity to form high molecular weight aggregates that cannot be dissociated with reduction or denaturation. Together, the results of this study provide new insights into the functional relationship between microfibrillar proteins and have important implications for understanding elastic fiber assembly.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961786

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  The microfibrillar proteins MAGP-1 and fibrillin-1 form a ternary complex with the chondroitin sulfate proteoglycan decorin.

Authors:  B C Trask; T M Trask; T Broekelmann; R P Mecham
Journal:  Mol Biol Cell       Date:  2000-05       Impact factor: 4.138

2.  Fibrillin degradation by matrix metalloproteinases: implications for connective tissue remodelling.

Authors:  J L Ashworth; G Murphy; M J Rock; M J Sherratt; S D Shapiro; C A Shuttleworth; C M Kielty
Journal:  Biochem J       Date:  1999-05-15       Impact factor: 3.857

Review 3.  Fibrillin-rich microfibrils: elastic biopolymers of the extracellular matrix.

Authors:  C M Kielty; T J Wess; L Haston; Jane L Ashworth; M J Sherratt; C A Shuttleworth
Journal:  J Muscle Res Cell Motil       Date:  2002       Impact factor: 2.698

Review 4.  The molecular genetics of Marfan syndrome and related microfibrillopathies.

Authors:  P N Robinson; M Godfrey
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

5.  Human microvascular lymphatic and blood endothelial cells produce fibrillin: deposition patterns and quantitative analysis.

Authors:  Antonella Rossi; Erica Gabbrielli; Marilisa Villano; Mario Messina; Francesco Ferrara; Elisabetta Weber
Journal:  J Anat       Date:  2010-10-11       Impact factor: 2.610

Review 6.  The stumbling block in lung repair of emphysema: elastic fiber assembly.

Authors:  Adrian Shifren; Robert P Mecham
Journal:  Proc Am Thorac Soc       Date:  2006-07

7.  Identification of the growth factor-binding sequence in the extracellular matrix protein MAGP-1.

Authors:  Thomas J Broekelmann; Nicholas K Bodmer; Robert P Mecham
Journal:  J Biol Chem       Date:  2020-01-27       Impact factor: 5.157

8.  Familial occurrence of typical and severe lethal congenital contractural arachnodactyly caused by missplicing of exon 34 of fibrillin-2.

Authors:  M Wang; C L Clericuzio; M Godfrey
Journal:  Am J Hum Genet       Date:  1996-11       Impact factor: 11.025

Review 9.  Tissue elasticity and the ageing elastic fibre.

Authors:  Michael J Sherratt
Journal:  Age (Dordr)       Date:  2009-12

10.  Mice lacking the extracellular matrix protein MAGP1 display delayed thrombotic occlusion following vessel injury.

Authors:  Claudio C Werneck; Cristina P Vicente; Justin S Weinberg; Adrian Shifren; Richard A Pierce; Thomas J Broekelmann; Douglas M Tollefsen; Robert P Mecham
Journal:  Blood       Date:  2008-02-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.